INTRODUCTION
NanoSphere researches, develops and commercializes a diverse line of product formulations based on the NanoSphere Delivery System™ to meet the needs of
healthcare providers, consumers and supplier. The NanoSphere Delivery System™ is the first to apply nanotechnology to improve the bioavailability and efficacy of essential ingredients and medications.
This disruptive technology introduces a significant advancement in these industries. NHS is the only nanotechnology company who plans to offer
vertically integrated, commercial lines.
PIONEERING NANO-BIOTECHNOLOGY COMPANY. WITH OVER 20 YEARS RESEARCHING AND DEVELOPING OUR PATENT-PENDING NANOSPHERE DELIVERY SYSTEM™.
PATENTED NANOSPHERE DELIVERY TECHNOLOGY™ INCREASES THE BIOAVAILABILITY AND BIOACTIVITY OF CANNABINOIDS.
NANOSPHERE HEALTH IS THE FIRST AND ONLY COMPANY TO NANO-SIZE AND ENCAPSULATE CANNABINOIDS, DRAMATICALLY CHANGING THE INDUSTRY.
227